Improving tuberculosis prevention and care through addressing the global diabetes epidemic: From evidence to policy and practice

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 9, 2014, Pages 730-739

  Lönnroth, Knut ^a   Roglic, Gojka ^a   Harries, Anthony D ^b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAPENTINE;

CHEMOPROPHYLAXIS; CLINICAL PRACTICE; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIDEMIC; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; INFECTION PREVENTION; INFECTION RISK; MEDICATION COMPLIANCE; PATIENT CARE; REVIEW; RISK ASSESSMENT; SCREENING TEST; TOTAL QUALITY MANAGEMENT; TREATMENT RESPONSE; TUBERCULOSIS; TUBERCULOSIS CONTROL; EVIDENCE BASED PRACTICE; HEALTH; MANAGEMENT; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PROCEDURES; PROGNOSIS; RISK FACTOR;

CHEMOPREVENTION; DIABETES MELLITUS; EVIDENCE-BASED PRACTICE; GLOBAL HEALTH; HEALTH POLICY; HUMANS; POLICY MAKING; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROGNOSIS; RISK FACTORS; TUBERCULOSIS;

EID: 84908283781     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70109-3     Document Type: Review

References (71)

1. Global tuberculosis report 2013. WHO/HTM/TB/2013.11 2013, WHO, World Health Organization, Geneva.
2. Dye C, Maher D, Weil D, Espinal M, Raviglione M Targets for global tuberculosis control. Int J Tuberc Lung Dis 2006, 10:460-462.
3. The Global Plan to Stop TB 2006-2015. WHO/HTM/STB/2006.35 2006, WHO, World Health Organization, Geneva.
4. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
5. Lönnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010, 375:1814-1829.
6. Raviglione M, Marais B, Floyd K, et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 2012, 379:1902-1913.
7. Nathanson E, Nunn P, Uplekar M, et al. MDR tuberculosis-critical steps for prevention and control. N Engl J Med 2010, 363:1050-1058.
8. WHO Sixty-Seventh World Health Assembly (2014). Global strategy and targets for tuberculosis prevention, care and control after 2015. A67/11 2014, WHO, World Health Organization, Geneva.
9. WHO tuberculosis programme: framework for effective tuberculosis control. WHO/TB/94.179 1994, WHO, World Health Organization, Geneva.
10. An expanded DOTS framework for effective tuberculosis control. WHO/CDS/TB/2002.297 2002, WHO, World Health Organization, Geneva.
11. The stop TB strategy. WHO/HTM/TB/2006.368 2006, WHO, World Health Organization, Geneva.
12. Creswell J, Raviglione M, Ottmani S, et al. Tuberculosis and non-communicable diseases: neglected links, missed opportunities. Eur Respir J 2011, 37:1269-1282.
13. Marais B, Lönnroth K, Lawn SD, et al. Tuberculosis co-morbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis 2013, 13:436-448.
14. Harries AD, Lin Y, Satyanarayana S, et al. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis. Int J Tuberc Lung Dis 2011, 15:1436-1444.
15. Harries AD, Satyanarayana S, Kumar AMV, et al. Epidemiology and interaction of diabetes mellitus and tuberculosis and the challenges for care: a review. Public Health Action 2013, 3:S3-S9.
16. Jeon CY, Harries AD, Baker MA, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health 2010, 15:1300-1314.
17. Stevenson CR, Critchley JA, Forouhi NG, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health?. Chronic Illn 2007, 3:228-245.
18. Jeon CY, Murray MB Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008, 5:e152.
19. Dooley KE, Chaisson RE Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis 2009, 9:737-746.
20. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJ, van Crevel R Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health 2010, 15:1289-1299.
21. Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 2011, 9:81.
22. Diabetes Atlas IDF 2000, International Diabetes Federation, International Diabetes Federation, Brussels. second edn.
23. Diabetes Atlas IDF 2006, International Diabetes Federation, International Diabetes Federation, Brussels. third edn.
24. Diabetes Atlas IDF 2013, International Diabetes Federation, International Diabetes Federation, Brussels. sixth edn.
25. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011, 378:31-40. the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose).
26. 134th session. Global strategy and targets for tuberculosis prevention, care and control after 2015. EB134.R4 2014, WHO Executive Board (2014), World Health Organization, Geneva.
27. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K Financial burden for tuberculosis patients in low- and middle-income countries-a systematic review. Eur Respir J 2014, 43:1763-1775.
28. Lönnroth K, Glaziou P, Weil D, Floyd K, Uplekar M, Raviglione M Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention. PLoS Med 2014, 11:e1001693.
29. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009, 68:2240-2246.
30. Goldhaber-Fiebert JD, Jeon CY, Cohen T, Murray MB Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. Int J Epidemiol 2011, 40:417-428.
31. Dye C, Bourdin Trunz B, Lönnroth K, Roglic G, Williams BG Nutrition, diabetes and tuberculosis in the epidemiological transition. PLoS One 2011, 6:e21161.
32. Odone A, Houben RM, Lönnroth K, White RG The effect of diabetes and undernutrition trrends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol 2014, 2:754-764.
33. Leung CC, Lam TH, Chan WM, et al. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 2008, 167:1486-1494.
34. Beagley J, Guariguata L, Weil C, Motala A Global estimates of undiagnosed diabetes in adults. Diab Res Clin Pract 2014, 103:150-160.
35. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000, 2. CD001363.
36. Pfaffenberg R, Jahler H Isoniazid and recurrence of tuberculosis in diabetics. Z Tuberk 1958, 111:167-173. (in German).
37. Lesnichii AV, Karpina LZ Experience with the chemoprophylaxis of pulmonary tuberculosis in diabetes mellitus patients. Probl Tuberk 1969, 47:1-3. (in Russian).
38. Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011, 365:2155-2166. the TB Trials Consortium PREVENT TB Study Team.
39. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. WHO/HTM/TB/2011.11 2011, WHO, World Health Organization, Geneva.
40. Recommendations for investigating the contacts of persons with infectious tuberculosis in low- and middle-income countries. WHO/HTM/TB/2012.9 2012, WHO, World Health Organization, Geneva.
41. Lönnroth K, Corbett E, Golub J, et al. Systematic screening for active tuberculosis: rationale, definitions and key considerations. Int J Tuberc Lung Dis 2013, 17:289-298.
42. Storla DG, Yimer S, Bjune GA A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 2008, 8:15.
43. Shapiro AE, Chakravorty R, Akande T, Lönnroth K, Golub JE A systematic review of the number needed to screen to detect a case of active tuberculosis in different risk groups (accessed Feb 1, 2014). http://www.who.int/tb/Review3NNS_case_active_TB_riskgroups.pdf?ua=1.
44. Lin Y, Li L, Mi F, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health 2012, 17:1302-1308.
45. Screening of patients with diabetes mellitus for tuberculosis in India. Trop Med Int Health 2013, 18:646-654. India Diabetes Mellitus-Tuberculosis Study Group.
46. Kranzer K, Afnan-Holmes H, Tomlin K, et al. The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review. Int J Tuberc Lung Dis 2013, 17:432-446.
47. Rocha C, Montoya R, Zevallos K, et al. The innovative socio-economic interventions against tuberculosis (ISIAT) project: an operational assessment. Int J Tuberc Lung Dis 2011, 15(suppl 2):S50-S57.
48. Volmink J, Garner P Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment. BMJ 1997, 315:1403-1406.
49. Wei X, Zou G, Yin J, et al. Providing financial incentives to rural-to-urban tuberculosis migrants in Shanghai: an intervention study. Infect Dis Poverty 2012, 1:9.
50. Ottmani SE, Murray MB, Jeon CY, et al. Consultation meeting on tuberculosis and diabetes mellitus: meeting summary and recommendations. Int J Tuberc Lung Dis 2010, 14:1513-1517.
51. Harries AD, Murray MB, Jeon CY, et al. Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis. Trop Med Int Health 2010, 15:659-663.
52. Collaborative framework for care and control of tuberculosis and diabetes. WHO/HTM/TB/2011.15 2011, WHO and The International Union Against Tuberculosis and Lung Disease, World Health Organization, Geneva.
53. Systematic screening for active tuberculosis: principles and recommendations. WHO/HTM/TB.2013.04 2013, WHO, World Health Organization, Geneva.
54. Riza AL, Pearson F, Ugarte-Gil C, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol 2014, 2:740-753.
55. Li L, Lin Y, Mi F, et al. Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health 2012, 17:1294-1301.
56. Screening of patients with tuberculosis for diabetes mellitus in India. Trop Med Int Health 2013, 18:636-645. India Tuberculosis-Diabetes Study Group.
57. Kishore B, Nagrath SP, Mathur KS, Hazra DK, Agarwal BD Manifest, chemical and latent chemical diabetes in pulmonary tuberculosis. J Assoc Physicians India 1973, 21:875-881.
58. Goyal BN, Nigam P, Dubey AL, Joshi LD, Saxena HN Study of the diabetic status in pulmonary tuberculosis. J Diabetes Assoc India 1978, 18:191-197.
59. Prakash BC, Ravish KS, Prabhakar B, et al. Tuberculosis-diabetes mellitus bidirectional screening at a tertiary care centre, south India. Public Health Action 2013, 3(suppl 1):S18-S22.
60. Dave P, Shah A, Chauhan M, et al. Screening patients with tuberculosis for diabetes mellitus in Gujarat, India. Public Health Action 2013, 3(suppl 1):S29-S33.
61. Naik B, Kumar AMV, Satyanarayana S, et al. Is screening for diabetes among tuberculosis patients feasible at the field level?. Public Health Action 2013, 3(suppl 1):S34-S37.
62. Nair S, Kumari AK, Subramonianpillai J, et al. High prevalence of undiagnosed diabetes among tuberculosis patients in peripheral health facilities in Kerala. Public Health Action 2013, 3(suppl 1):S38-S42.
63. Achanta S, Tekumalla RR, Jaju J, et al. Screening tuberculosis patients for diabetes in a tribal area in south India. Public Health Action 2013, 3(suppl 1):S43-S47.
64. Kumpatla S, Sekar A, Achanta S, et al. Characteristics of patients with diabetes screened for tuberculosis in a tertiary care hospital in south India. Public Health Action 2013, 3(suppl 1):S23-S28.
65. Singh MM, Biswas SK, Shah A Impaired glucose tolerance in active pulmonary tuberculosis. Indian J Tuberc 1984, 31:118-121.
66. Oluboyo PO, Erasmus RT The significance of glucose intolerance in pulmonary tuberculosis. Tubercle 1990, 71:135-138.
67. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101. the China National Diabetes and Metabolic Disorders Study Group.
68. Adepoyibi T, Weigl B, Greb H, Neogi T, McGuire H New screening technologies for type 2 diabetes mellitus appropriate for use in tuberculosis patients. Public Health Action 2013, 3(suppl 1):S10-S17.
69. Global action plan for the prevention and control of noncommunicable diseases 2013-2020 WHO, (accessed Feb 1, 2014). http://www.who.int/nmh/events/ncd_action_plan/en/.
70. Contributing to health system strengthening-guiding principles for national tuberculosis programmes. WHO/HTM/TB/2008.400 2008, WHO, World Health Organization, Geneva.
71. New funding model The global fund: to fight AIDs, tuberculosis and malaria, (accessed Feb 17, 2014). http://www.theglobalfund.org/en/about/grantmanagement/fundingmodel/.